Changes in Radiation Sensitivity and Steroid Receptor Content Induced by Hormonal Agents and Ionizing Radiation in Breast Cancer Cells in Vitro

References

• Lundgren S. Review: Prospects in endocrine treatment of breast cancer. The Cancer Journal 1994; 7: 220–7
   Google Scholar
• Hug V., Hortobagyi G. N., Drewinko B., Finders M. Tamoxifen-citrate counteracts the antitumor effects of cytotoxic drugs in vitro. J Clin Oncol 1985; 3: 1672–7
   PubMedGoogle Scholar
• Osborne C. K., Kitten L., Arteaga C. L. Antagonism of chemotherapinduced cytotoxicity for human breast cancer cells by antiestrogens. J Clin Oncol 1989; 7: 710–7
   PubMed Web of Science ®Google Scholar
• Wazer D. E., Tercilla O. F., Lin P. S., Schmidt-Ullrich R. Modulation in the radiosensitivity of the MCF-7 human breast carcinoma cells by 17B-estradiol and tamoxifen. Br J Radiol 1989; 62: 1079–83
   PubMed Web of Science ®Google Scholar
• Wazer D. E., Joyce M., Solares G., Schmidt-Ullrich R. Proliferative inhibition of the human breast carcinoma ceils by high concentration estradiol does not alter radiosensitivity. Breast Cancer Res Treat 1991; 18: 141–8
   PubMedGoogle Scholar
• Kantorowitz D. A., Thompson H. J., Furmanski P. Effects of cojoint administration of tamoxifen and high-dose radiation on the development of mammary carsinoma. Int J Radiat Oncol Biol Phys 1993; 26: 89–94
   PubMedGoogle Scholar
• Schmidt-Ullrich R. K., Valerie K. C., Chan W., McWilliams D. Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures. Int J Radiat Oncol Biol Phys 1994; 29: 813–9
   PubMedGoogle Scholar
• Schmidt-Ullrich R. K., Valerie K., Chan W., Wazer D. E. Expression of oestrogen receptor and transforming growth factor-a in MCF-7 cells after exposure to fractionated irradiation. Int J Radiat Biol 1992; 61: 405–15
   PubMed Web of Science ®Google Scholar
• Soule H. D., Vazques J., Long A., Albert S., Brennan M. A. Human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973; 51: 1409–16
   PubMed Web of Science ®Google Scholar
• Lippman M. E., Bolan G., Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 1976; 36: 4595–601
   PubMed Web of Science ®Google Scholar
• Horwitz K. B., Costlow M. E., McGuire W. L. MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids 1975; 26: 785–95
   PubMed Web of Science ®Google Scholar
• Cailleau R., Yong R., Olivé M, Reeves WJ, Jr. Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 1974; 53: 661–74
   PubMed Web of Science ®Google Scholar
• Lykkesfeldt A. E., Madsen M. W., Briand P. Altered expression of oestrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,78. sensitive human breast cancer cell line, MCF-7/TAMR-l. Cancer Res 1994; 54: 1587–95
   PubMed Web of Science ®Google Scholar
• Lykkesfeldt A. E., Sarensen E. K. Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline AL-1. Acta Oncol 1992; 31: 131–8
   PubMed Web of Science ®Google Scholar
• Lien E. A., Solheim E., Lea O. A., Lundgren S., Kvinnsland S., Ueland P. M. Distribution of 4-hydroxy-N-desmethyltamo-xifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment. Cancer Res 1989; 49: 2175–83
   PubMed Web of Science ®Google Scholar
• Roberts S. A. DRFIT: A program for fitting radiation survival models. Int J Radiat Biol 1990; 57: 1243–6
   PubMed Web of Science ®Google Scholar
• Fertil B., Dertinger H., Courdi A., Malaise E. P. Mean inactiva-tion dose: A useful concept for intercomparison of human cell survival curves. Radiat Res 1984; 99: 73–84
   PubMed Web of Science ®Google Scholar
• Berthois Y., Katzenellenbogen J. A., Katzenellenbogen B. S. Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 1986; 83: 2496–500
   PubMed Web of Science ®Google Scholar
• Butler W. B., Kelsey W. H., Goran N. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens. Cancer Res 1981; 41: 82–8
   PubMed Web of Science ®Google Scholar
• Germain P., Harbrioux G. Modulation of the estradiol-17 beta mitogenic effect on human breast cancer MCF-7 cells by serum albumin in defined medium. Anticancer Res 1993; 13: 1581–5
   PubMedGoogle Scholar
• Page M. J., Field J. K., Everett N. P., Green C. D. Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. Cancer Res 1983; 43: 1244–50
   PubMed Web of Science ®Google Scholar
• Reddel R. R., Sutherland R. L. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Cancer Res 1987; 47: 5323–9
   PubMedGoogle Scholar
• Brünner N., Bronzert D., Vindeløv L. L., Rygaard K., Spang-Thompson M., Lippman M. E. Effects on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Cancer Res 1989; 49: 1515–20
   PubMed Web of Science ®Google Scholar
• Furuya Y., Kohno N., Fujiwara Y., Saitoh Y. Mechanisms of estrogen action on the proliferation of MCF-7 human breast cancer cells in an improved culture medium. Cancer Res 1989; 49: 6670–4
   PubMedGoogle Scholar
• Briand P., Lykkesfeldt A. E. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration. Cancer Res 1984; 44: 1114–9
   PubMed Web of Science ®Google Scholar
• Sarkaria J. N., Miller E. M., Parker C. J., Jordan C., Mulcahy R. T. 4-Hydroxytamoxifen, an active metabolite of tamoxifen, does not alter the radiation sensitivity of MCF-7 breast carcinoma cells irradiated in vitro. Breast Cancer Res Treat 1994; 30: 159–65
   PubMedGoogle Scholar
• Sutherland R. L., Hall R. E., Taylor IW. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and the effects of tamoxifen on exponentially growing and plateau-phase cells. Cancer Res 1983; 43: 3998–4006
   PubMed Web of Science ®Google Scholar
• Thompson E. W., Reich R., Shima T. B., et al. Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. Cancer Res 1988; 48: 6764–8
   PubMed Web of Science ®Google Scholar
• Bruno S., Di Vinci A., Geido E., Giaretti W. Cell cycle synchronization induced by tamoxifen and 17b-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine. Breast Cancer Res Treat 1988; 11: 221–9
   PubMedGoogle Scholar
• Osborne C. K., Boldt D. H., Estrada P. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture. Cancer Res 1984; 44: 1433–9
   PubMed Web of Science ®Google Scholar
• Sutherland R. L., Green M. D., Hall R. E., Reddel R. R., Taylor I. W. Tamoxifen induces accumulation of MCF-7 human mammary carcinoma cells in the Go/G1 phase of the cell cycle. Eur J Cancer Clin Oncol 1983; 19: 615–21
   PubMedGoogle Scholar
• Sinclair W. K. Cyclic x-ray responses in mammalian cells in vitro. Radiat Res 1968; 33: 620–43
   PubMed Web of Science ®Google Scholar
• Lundgren S., Seireide J. A., Lea O. A. Influence of tamoxifen on the tumor content of steroid hormone receptors (ER PgR and AR) in patients with primary breast cancer. Anticancer Res 1994; 14: 1313–6
   PubMedGoogle Scholar